These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 33391414)

  • 1. Loss of LIMCH1 predicts poor prognosis in patients with surgically resected Lung Adenocarcinoma: A study based on Immunohistochemical Analysis and Bioinformatics.
    Cao H; Zhao J; Chen Z; Sun W; Ruan K; Zhou J; Zhou J
    J Cancer; 2021; 12(1):181-189. PubMed ID: 33391414
    [No Abstract]   [Full Text] [Related]  

  • 2. A signature of tumor DNA repair genes associated with the prognosis of surgically-resected lung adenocarcinoma.
    Yang X; Wang G; Gu R; Xu X; Zhu G
    PeerJ; 2020; 8():e10418. PubMed ID: 33304656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validating
    Li X; Zuo H; Zhang L; Sun Q; Xin Y; Zhang L
    Front Oncol; 2021; 11():720302. PubMed ID: 34527588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and prognostic analysis of Rho GTPase-activating protein 11A in lung adenocarcinoma.
    Chen S; Duan H; Xie Y; Li X; Zhao Y
    Ann Transl Med; 2021 May; 9(10):872. PubMed ID: 34164506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated Heterogeneous Nuclear Ribonucleoprotein C Expression Correlates With Poor Prognosis in Patients With Surgically Resected Lung Adenocarcinoma.
    Guo W; Huai Q; Zhang G; Guo L; Song P; Xue X; Tan F; Xue Q; Gao S; He J
    Front Oncol; 2020; 10():598437. PubMed ID: 33569346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of Family with Sequence Similarity 83, Member A (FAM83A) Predicts Poor Clinical Outcomes in Lung Adenocarcinoma.
    Zhang JT; Lin YC; Xiao BF; Yu BT
    Med Sci Monit; 2019 Jun; 25():4264-4272. PubMed ID: 31175804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FUT4 is involved in PD-1-related immunosuppression and leads to worse survival in patients with operable lung adenocarcinoma.
    Liu C; Li Z; Wang S; Fan Y; Zhang S; Yang X; Hou K; Tong J; Hu X; Shi X; Wang X; Liu Y; Che X; Qu X
    J Cancer Res Clin Oncol; 2019 Jan; 145(1):65-76. PubMed ID: 30357521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of SLC35F2 is a potential prognostic biomarker for lung adenocarcinoma.
    Zheng Q; Li M; Qiu Y; Yang J; Cao Y
    Heliyon; 2024 Jan; 10(1):e23828. PubMed ID: 38187235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon Regulatory Factor 4 Correlated With Immune Cells Infiltration Could Predict Prognosis for Patients With Lung Adenocarcinoma.
    Li X; Zhai S; Zhang J; Zhang D; Wang S; Wang L; Yu J
    Front Oncol; 2021; 11():698465. PubMed ID: 34195096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High expression of PIMREG predicts poor survival outcomes and is correlated with immune infiltrates in lung adenocarcinoma.
    Jiang F; Liang M; Huang X; Shi W; Wang Y
    PeerJ; 2021; 9():e11697. PubMed ID: 34268011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased INPP5B expression predicts poor prognosis in lung adenocarcinoma.
    Deng J; Lin X; Li Q; Cai XY; Wu LW; Wang W; Zhang B; Li YL; Hu J; Lin NM
    Cancer Cell Int; 2022 May; 22(1):189. PubMed ID: 35568951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low expression of IL6R predicts poor prognosis for lung adenocarcinoma.
    Sun G; Wang T; Shi M; Zhou H; Wang J; Huang Z; Zhang H; Shi J
    Ann Transl Med; 2021 Jul; 9(13):1057. PubMed ID: 34422969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased Expression of
    Deng P; Zhou R; Zhang J; Cao L
    J Cancer; 2021; 12(11):3239-3248. PubMed ID: 33976733
    [No Abstract]   [Full Text] [Related]  

  • 14. Overexpression of LncRNA-UCA1 Correlates with Lung Adenocarcinoma Progression and Poor Prognosis.
    Chen L; Cao P; Wu Q; Guo Y; Yang Y; Chen F
    Clin Lab; 2019 Mar; 65(3):. PubMed ID: 30868851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. INHA acts as a novel and potential biomarker in lung adenocarcinoma and shapes the immune-suppressive tumor microenvironment.
    Zhang X; Zhang X; Jiang D; Zheng W; Wang H; Tian Y; Cheng B
    Transl Oncol; 2023 Jul; 33():101679. PubMed ID: 37105130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of abnormal spindle-like microcephaly-associated (ASPM) increases tumor aggressiveness and predicts poor outcome in patients with lung adenocarcinoma.
    Feng Z; Zhang J; Zheng Y; Liu J; Duan T; Tian T
    Transl Cancer Res; 2021 Feb; 10(2):983-997. PubMed ID: 35116426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AUNIP Expression Is Correlated With Immune Infiltration and Is a Candidate Diagnostic and Prognostic Biomarker for Hepatocellular Carcinoma and Lung Adenocarcinoma.
    Ma C; Kang W; Yu L; Yang Z; Ding T
    Front Oncol; 2020; 10():590006. PubMed ID: 33363020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low expression of CHRDL1 and SPARCL1 predicts poor prognosis of lung adenocarcinoma based on comprehensive analysis and immunohistochemical validation.
    Deng H; Hang Q; Shen D; Zhang Y; Chen M
    Cancer Cell Int; 2021 May; 21(1):259. PubMed ID: 33980221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated FAM83A expression predicts poorer clincal outcome in lung adenocarcinoma.
    Zhang J; Sun G; Mei X
    Cancer Biomark; 2019; 26(3):367-373. PubMed ID: 31594212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plakophilin-2 accelerates cell proliferation and migration through activating EGFR signaling in lung adenocarcinoma.
    Hao XL; Tian Z; Han F; Chen JP; Gao LY; Liu JY
    Pathol Res Pract; 2019 Jul; 215(7):152438. PubMed ID: 31126818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.